Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

1. Del Barco, S.
2. Colomer, R.
3. Calvo, L.
4. Tusquets, I.
5. Adrover, E.
6. Sánchez, P.
7. Rifà, J.
8. De La Haba, J.
9. Virizuela, J.A.